Raw Material Optimization to Bend the Biopharmaceutical Cost Curve

Raw materials sourced from sole third-party suppliers have been identified as one of the key risks to Amgen’s operation. This project aims to reduce raw material costs through sourcing alternative materials and optimizing material consumption. To systematically evaluate alternative material supp...

Descrición completa

Detalles Bibliográficos
Autor Principal: Chen, Julia Mengpei
Outros autores: Zheng, Yanchong
Formato: Thesis
Publicado: Massachusetts Institute of Technology 2022
Acceso en liña:https://hdl.handle.net/1721.1/139545